Direct From The Experts

Below is a list of some of the already existing Peer-reviewed and Published research citations related to Electronic Vapor Products (Electronic cigarettes):

  • Adkison S., O’Connor R., Bansal-Travers M., Hyland A., Borland R., Yong H.H., et al. (2013) Electronic nicotine delivery systems: international tobacco control four-country survey. Am J Prev Med 44: 207–215 [PMC free article] [PubMed]                                             
  • Antal M., Mok W., Roy J., T-Raissi A. (1985) Pyrolytic sources of hydrocarbons from biomass. J Anal Appl Pyrol 8: 291–303                     
  • Bahl V., Lin S., Xu N., Davis B., Wang Y., Talbot P. (2012) Comparison of electronic cigarette refill fluid cytotoxicity using embryonic and adult models. Reprod Toxicol 34: 529–537 [PubMed]                                                
  • Bertholon J., Becquemin M., Roy M., Roy F., Ledur D., Annesi Maesano I., et al. (2013) Comparison of the aerosol produced by electronic cigarettes with conventional cigarettes and the shisha. Rev Mal Respir 30: 752–757 [PubMed]                      
  • Bullen C., Howe C., Laugesen M., McRobbie H., Parag V., Williman J., et al. (2013) Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet 382: 1629–1637 [PubMed]           
  • Burstyn I. (2014) Peering through the mist: Systematic review of what the chemistry of contaminants in electronic cigarettes tells us about health risks. BMC Public Health 14: 18. [PMC free article] [PubMed]     
  • Cahn Z., Siegel M. (2011) Electronic cigarettes as a harm reduction strategy for tobacco control: a step forward or a repeat of past mistakes? J Public Health Policy 32: 16–31 [PubMed]       
  • Camenga D., Delmerico J., Kong G., Cavallo D., Hyland A., Cummings K., et al. (2013) Trends in use of electronic nicotine delivery systems by adolescents. Addict Behav 39(1): 338–340 [PMC free article] [PubMed]            
  • Cantrell F. (2013) Adverse effects of e-cigarette exposures. J Community Health 15 December 2013. (Epub ahead of print). DOI: 10.1007/s10900-013-9807-5 [PubMed] [Cross Ref] 
  • Caponnetto P., Auditore R., Russo C., Cappello G., Polosa R. (2013a) Impact of an electronic cigarette on smoking reduction and cessation in schizophrenic smokers: a prospective 12-month pilot study. Int J Environ Res Public Health 10: 446–461 [PMC free article] [PubMed]                
  • Caponnetto P., Campagna D., Cibella F., Morjaria J., Caruso M., Russo C., et al. (2013b) EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One 8: e66317. [PMC free article] [PubMed]
  • Caponnetto P., Polosa R., Auditore R., Russo C., Campagna D. (2011a) Smoking cessation with e-cigarettes in smokers with a documented history of depression and recurring relapses. Int J Clin Med 2: 281–284                
  • Caponnetto P., Polosa R., Russo C., Leotta C., Campagna D. (2011b) Successful smoking cessation with electronic cigarettes in smokers with a documented history of recurring relapses: a case series. J Med Case Rep 5: 585. [PMC free article] [PubMed]
  •  Chen I. (2013) FDA summary of adverse events on electronic cigarettes. Nicotine Tob Res 15: 615–616 [PubMed]                    
  • Czogala J., Goniewicz M., Fidelus B., Zielinska-Danch W., Travers M., Sobczak A. (2013) Secondhand exposure to vapors from electronic cigarettes. Nicotine Tob Res (11 December 2011 (Epub ahead of print). DOI: 10.1093/ntr/ntt203 [PubMed] [Cross Ref]                
  •  Dawkins L. (2013) Electronic cigarettes: what are they and are they effective? E-Cigarette Summit, London, UK: (oral presentation). Available at: http://e-cigarette-summit.com/wp-content/uploads/2013/12/Summit-Presentations.pdf [accessed 22 December 2013].  
  • Dawkins L., Corcoran O. (2013) Acute electronic cigarette use: nicotine delivery and subjective effects in regular users. Psychopharmacology (Berl) 231: 401–407 [PubMed]
  • Dawkins L., Turnern J., Roberts A., Soar K. (2013) ‘Vaping’ profiles and preferences: an online survey of electronic cigarette users. Addiction 108: 1115–1125 [PubMed]
  • Dockrell M., Morison R., Bauld L., McNeill A. (2013) E-Cigarettes: prevalence and attitudes in Great Britain. Nicotine Tob Res 15: 1737–1744 [PMC free article] [PubMed]
  • Douptcheva N., Gmel G., Studer J., Deline S., Etter J.F. (2013) Use of electronic cigarettes among young Swiss men. J Epidemiol Community Health 67: 1075–1076 [PubMed]
  • Etter J., Bullen C. (2011) Electronic cigarette: users profile, utilization, satisfaction and perceived efficacy. Addiction 106: 2017–2028 [PubMed]
  • Etter J., Zäther E., Svensson S. (2013) Analysis of refill liquids for electronic cigarettes. Addiction 108: 1671–1679 [PubMed]
  • Farsalinos K., Romagna G. (2013) Chronic idiopathic neutrophilia in a smoker, relieved after smoking cessation with the use of electronic cigarette: a case report. Clin Med Insights Case Rep 6: 15–21 [PMC free article] [PubMed]
  • Farsalinos K., Romagna G., Allifranchini E., Ripamonti E., Bocchietto E., Todeschi S., et al. (2013a) Comparison of the cytotoxic potential of cigarette smoke and electronic cigarette vapour extract on cultured myocardial cells. Int J Environ Res Public Health 10: 5146–5162 [PMC free article] [PubMed]
  • Farsalinos K., Romagna G., Tsiapras D., Kyrzopoulos S., Voudris V. (2013b) Evaluating nicotine levels selection and patterns of electronic cigarette use in a group of “vapers” who had achieved complete substitution of smoking. Subst Abuse 7: 139–146 [PMC free article] [PubMed]
  • Farsalinos K., Romagna G., Tsiapras D., Kyrzopoulos S., Voudris V. (2013c) Evaluation of electronic cigarette use (vaping) topography and estimation of liquid consumption: implications for research protocol standards definition and for public health authorities’ regulation. Int J Environ Res Public Health 10: 2500–2514 [PMC free article] [PubMed]
  • Farsalinos K., Romagna G., Voudris V. (2013d) Authors miss the opportunity to discuss important public health implications. J Chromatogr A 1312: 155–156 [PubMed]
  • Farsalinos K., Spyrou A., Tsimopoulou K., Stefopoulos C., Romagna G., Voudris V. (2014). Nicotine absorption from electronic cigarette use: comparison between first and new-generation devices. Sci Rep (in press). [PMC free article] [PubMed]
  • Farsalinos KE, Tsiapras D, Kyrzopoulos S, Savvopoulou M, Voudris V. Acute effects of using an electronic nicotine-delivery device (electronic cigarette) on myocardial function: comparison with the effects of regular cigarettes. BMC Cardiovasc Disord. 2014 Jun 23;14:78 [PMC free article] [PubMed]
  • Farsalinos K., Tsiapras D., Kyrzopoulos S., Stefopoulos C., Spyrou A., Tsakalou M., et al. (2013f) Immediate effects of electronic cigarette use on coronary circulation and blood carboxyhemoglobin levels: comparison with cigarette smoking. Eur Heart J 34(Abstract Supplement): 13.
  • Farsalinos KE, Kistler KA, Gillman G, Voudris V. (2013f) Evaluation of Electronic Cigarette Liquids and Aerosol for the Presence of Selected Inhalation Toxins. PMC free article] [PubMed]
  • Farsalinos KE, Polosa R. JAMA Pediatr. 2014 Aug;168(8):775. doi: 10.1001/jamapediatrics.2014.727. No abstract available. PMID: 25090295 [PubMed – in process] Related citations Select item 25083263PMC free article] [PubMed]
  • Farsalinos KE, Polosa R. JAMA Pediatr. 2014 Aug;168(8):775. doi: 10.1001/jamapediatrics.2014.727. No abstract available. PMID: 25090295 [PubMed – in process] Related citations Select item 25083263PMC free article] [PubMed]
  • Farsalinos KE, Polosa R. Ther Adv Drug Saf. 2014 Apr;5(2):67-86. doi: 10.1177/ 2042098614524430. Review. PMID: 25083263 [PubMed] Free PMC Article Related citations Select item 25017651 Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review.PubMed]
  • Farsalinos KE, Romagna G, Le Houezec J. Semin Thromb Hemost. 2014 Jun;40(4):517-8. doi: 10.1055/s-0034- 1375702. Epub 2014 May 6. No abstract available. PMID: 24802086 [PubMed – in process] Related citations Select item 24780218Comment on “E-cigarettes and cardiovascular risk: beyond science and mysticism”.PubMed]
  • Farsalinos KE, Romagna G, Voudris V. Toxicol In Vitro. 2014 Aug;28(5):1016-7. doi: 10.1016/j.tiv.2014.04.016. Epub 2014 Apr 26. No abstract available. PMID: 24780218 [PubMed – in process] Related citations Select item 24758891Cytotoxicity of cinnamon-flavored electronic cigarette refills: are the results truly applicable to electronic cigarette use?PubMed]
  • Farsalinos KE, Romagna G, Tsiapras D, Kyrzopoulos S, Voudris V. Int J Environ Res Public Health. 2014 Apr 22;11(4):4356-73. doi: 10.3390/ ijerph110404356. PMID: 24758891 [PubMed – in process] Free PMC Article Related citations Select item 24709413Characteristics, perceived side effects and benefits of electronic cigarette use: a worldwide survey of more than 19,000 consumers.PubMed]
  • Flouris A., Chorti M., Poulianiti K., Jamurtas A., Kostikas K., Tzatzarakis M., et al. (2013) Acute impact of active and passive electronic cigarette smoking on serum cotinine and lung function. Inhal Toxicol 25: 91–101 [PubMed]
  • Flouris A., Poulianiti K., Chorti M., Jamurtas A., Kouretas D., Owolabi E., et al. (2012) Acute effects of electronic and tobacco cigarette smoking on complete blood count. Food Chem Toxicol 50: 3600–3603 [PubMed]
  • Goniewicz M., Knysak J., Gawron M., Kosmider L., Sobczak A., Kurek J., et al. (2013) Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control. DOI: (Published online: 6 March 2013).10.1136/tobaccocontrol-2012-050859 [PMC free article] [PubMed] [Cross Ref]
  • Greenland S., Satterfield M., Lanes S. (1998) A meta-analysis to assess the incidence of adverse effects associated with the transdermal nicotine patch. Drug Safety 18: 297–308 [PubMed]
  • Guillem K., Vouillac C., Azar M., Parsons L., Koob G., Cador M., et al. (2005) Monoamine oxidase inhibition dramatically increases the motivation to self-administer nicotine in rats. J Neurosci 25: 8593–8600 [PubMed]
  • Guslandi M. (1999) Nicotine treatment for ulcerative colitis. Br J Clin Pharmacol 48: 481–484 [PMC free article] [PubMed]
  •  Hadwiger M., Trehy M., Ye W., Moore T., Allgire J., Westenberger B. (2010) Identification of amino-tadalafil and rimonabant in electronic cigarette products using high pressure liquid chromatography with diode array and tandem mass spectrometric detection. J Chromatogr A 1217: 7547–7555 [PubMed]
  • Hajek P., Jarvis M., Belcher M., Sutherland G., Feyerabend C. (1989) Effect of smoke-free cigarettes on 24 h cigarette withdrawal: a double-blind placebo-controlled study. Psychopharmacology (Berl) 97: 99–102 [PubMed]
  • Hubbard R., Lewis S., Smith C., Godfrey C., Smeeth L., Farrington P., et al. (2005) Use of nicotine replacement therapy and the risk of acute myocardial infarction, stroke, and death. Tob Control 14: 416–421 [PMC free article] [PubMed]
  • Kim H., Shin H. (2013) Determination of tobacco-specific nitrosamines in replacement liquids of electronic cigarettes by liquid chromatography-tandem mass spectrometry. J Chromatogr A 1291: 48–55 [PubMed]
  • King B., Alam S., Promoff G., Arrazola R., Dube S. (2013) Awareness and ever use of electronic cigarettes among US adults, 2010–2011. Nicotine Tob Res 15(9): 1623–1627 [PubMed]
  • Laugesen M. (2008) Safety Report on the Ruyan® e-cigarette Cartridge and Inhaled Aerosol. Available at: http://www.healthnz.co.nz/RuyanCartridgeReport30-Oct-08.pdf (Accessed: 18 November 2013).
  • Laugesen M. (2009). Ruyan®E-cigarette Bench-top tests. Society for Research on Nicotine and Tobacco (SRNT) Dublin, Poster 5-11. Available at: http://www.healthnz.co.nz/DublinEcigBenchtopHandout.pdf [accessed 20 November 2013].
  • Le Houezec J., McNeill A., Britton J. (2011) Tobacco, nicotine and harm reduction. Drug Alcohol Rev 30: 119–123 [PubMed]
  • Lee S., Grana R., Glantz S. (2013) Electronic cigarette use among Korean adolescents: a cross-sectional study of market penetration, dual use, and relationship to quit attempts and former smoking. J Adolesc Health. DOI: (Published online: 22 November 2013).10.1016/j.jadohealth.2013.11.003 [PMC free article] [PubMed] [Cross Ref]
  • Lotfipour S., Arnold M., Hogenkamp D., Gee K., Belluzzi J., Leslie F. (2011) The monoamine oxidase (MAO) inhibitor tranylcypromine enhances nicotine self-administration in rats through a mechanism independent of MAO inhibition. Neuropharmacology 61: 95–104 [PMC free article] [PubMed]
  • Lúdvíksdóttir D., Blöndal T., Franzon M., Gudmundsson T., Säwe U. (1999) Effects of nicotine nasal spray on atherogenic and thrombogenic factors during smoking cessation. J Intern Med 246: 61–66 [PubMed]
  • Mayer B. (2013). How much nicotine kills a human? Tracing back the generally accepted lethal dose to dubious self-experiments in the nineteenth century. Arch Toxicol 88: 5–7 [PMC free article] [PubMed]
  • McAuley T., Hopke P., Zhao J., Babaian S. (2012) Comparison of the effects of e-cigarette vapor and cigarette smoke on indoor air quality. Inhal Toxicol 24: 850–857 [PubMed]
  • McCauley L., Markin C., Hosmer D. (2012) An unexpected consequence of electronic cigarette use. Chest 141(4): 1110–1113 [PubMed]
  • McClernon F., Hiott F., Westman E., Rose J., Levin E. (2006) Transdermal nicotine attenuates depression symptoms in nonsmokers: a double-blind, placebo-controlled trial. Psychopharmacology (Berl) 189: 125–133 [PubMed]
  • MHRA Commission on human medicines, Working Group on nicotine containing products (NCPS) (2013). Current use of electronic cigarettes. Available at: http://www.mhra.gov.uk/home/groups/comms-ic/documents/websiteresources/con286845.pdf (Accessed: 20 November 2013).
  • Moore D., Aveyard P., Connock M., Wang D., Fry-Smith A., Barton P. (2009) Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: systematic review and meta-analysis. BMJ 338: b1024. [PMC free article] [PubMed]
  • Murray R., Bailey W., Daniels K., Bjornson W., Kurnow K., Connett J., et al. (1996) Safety of nicotine polacrilex gum used by 3,094 participants in the Lung Health Study. Lung Health Study Research Group. Chest 109: 438–445 [PubMed]
  • Nides M., Leischow S., Bhatter M., Simmons M. (2014) Nicotine blood levels and short-term smoking reduction with an electronic nicotine delivery system. Am J Health Behav 38: 265–274 [PubMed]
  • Nielsen S., Franklin G., Longstreth W., Swanson P., Checkoway H. (2013) Nicotine from edible Solanaceae and risk of Parkinson disease. Ann Neurol 74: 472–477 [PubMed]
  • Palamidas A., Gennimata S., Kaltsakas G., Tsikrika S., Vakali S., Gratziou C., et al. (2013) Acute effect of an e-cigarette with and without nicotine on lung function. Presented at the European Respiratory Society’s Annual Congress, Poster P1054 Available at: http://www.ersnet.org/learning_resources_player/abstract_print_13/files/100.pdf (Accessed: 20 November 2013).
  • Pellegrino R., Tinghino B., Mangiaracina G., Marani A., Vitali M., Protano C., et al. (2012) Electronic cigarettes: an evaluation of exposure to chemicals and fine particulate matter (PM). Ann Ig 24: 279–288 [PubMed]
  • Peters A. (2005) Particulate matter and heart disease: evidence from epidemiological studies. Toxicol Appl Pharmacol 207: 477–482 [PubMed]
  • Polosa R., Caponnetto P. (2013) Time for evidence-based e-cigarette regulation. Lancet Oncol 14: 582–583 [PubMed]
  • Polosa R., Caponnetto P., Morjaria J., Papale G., Campagna D., Russo C. (2011) Effect of an electronic nicotine delivery device (e-Cigarette) on smoking reduction and cessation: a prospective 6-month pilot study. BMC Public Health 11: 786. [PMC free article] [PubMed]
  • Polosa R., Morjaria J., Caponnetto P., Campagna D., Russo C., Alamo A., et al. (2013a) Effectiveness and tolerability of electronic cigarette in real-life: a 24-month prospective observational study. Intern Emerg Med. DOI: (Published online: July 2013).10.1007/s11739-013-0977-z [PubMed] [Cross Ref]
  • Polosa R., Rodu B., Caponnetto P., Maglia M., Raciti C. (2013b) A fresh look at tobacco harm reduction: the case for the electronic cigarette. Harm Reduct J 10: 19. [PMC free article] [PubMed]
  • Ravindra K., Wauters E., Van Grieken R. (2008) Variation in particulate PAHs levels and their relation with the transboundary movement of the air masses. Sci Total Environ 396: 100–110 [PubMed]
  • Renne R., Wehner A., Greenspan B., Deford H., Ragan H., Westenberg R., et al. (1992) 2-Week and 13-Week Inhalation Studies of Aerosolized Glycerol in Rats. Inhal Toxicol 4: 95–111
  •  Riess U., Tegtbur U., Fauck C., Fuhrmann F., Markewitz D., Salthammer T. (2010) Experimental setup and analytical methods for the non-invasive determination of volatile organic compounds, formaldehyde and NOx in exhaled human breath. Anal Chim Acta 669: 53–62 [PubMed]
  • Robertson O., Loosli C., Puck T., Wise H., Lemon H., Lester W., Jr (1947) Tests for the chronic toxicity of propylene glycol and triethylene glycol on monkeys and rats by vapor inhalation and oral administration. J Pharmacol Exp Ther 91: 52–76 [PubMed]
  • Rodu B., Godshall W. (2006) Tobacco harm reduction: An alternative cessation strategy for inveterate smokers. Harm Reduct J 3: 37. [PMC free article] [PubMed]
  • Romagna G., Allifranchini E., Bocchietto E., Todeschi S., Esposito M., Farsalinos K. (2013) Cytotoxicity evaluation of electronic cigarette vapor extract on cultured mammalian fibroblasts (ClearStream-LIFE): comparison with tobacco cigarette smoke extract. Inhal Toxicol 25: 354–361 [PubMed]
  • Romagna G., Zabarini L., Barbiero L., Bocchietto E., Todeschi S., Caravati E., et al. (2012) Characterization of chemicals released to the environment by electronic cigarettes use (ClearStream-Air project): is passive vaping a reality? SRNT Europe Annual Congress, Helsinki, Finland Poster RRP18. Available at: http://www.srnteurope.org/assets/srnt-e2012abstractbook.pdf [accessed 20 November 2013].
  • Rose J. (2006) Nicotine and nonnicotine factors in cigarette addiction. Psychopharmacology (Berl) 184: 274–285 [PubMed]
  • Russell M. (1991) The future of nicotine replacement. Br J Addict 86: 653–658 [PubMed]
  • Sahakian B., Jones G., Levy R., Gray J., Warburton D.(1989) The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type. Br J Psychiatry 154: 797–800 [PubMed]
  • Saitta D., Ferro G., Polosa R. (2014) Achieving appropriate regulations for electronic cigarettes. Ther Adv Chronic Dis 3 February 2014 (Epub ahead of print). DOI: 10.1177/2040622314521271 [PMC free article] [PubMed]
  • Schiller J., Ni H. (2006) Cigarette smoking and smoking cessation among persons with chronic obstructive pulmonary disease. Am J Health Promot 20: 319–323 [PubMed]
  • Schober W., Szendrei K., Matzen W., Osiander-Fuchs H., Heitmann D., Schettgen T., et al. (2013) Use of electronic cigarettes (e-cigarettes) impairs indoor air quality and increases FeNO levels of e-cigarette consumers. Int J Hyg Environ Health. DOI: (Published online: 6 December 2013).10.1016/j.ijheh.2013.11.003 [PubMed] [Cross Ref]
  • Schripp T., Markewitz D., Uhde E., Salthammer T. (2013) Does e-cigarette consumption cause passive vaping? Indoor Air 23: 25–31 [PubMed]
  • Seaton A., MacNee W., Donaldson K., Godden D. (1995) Particulate air pollution and acute health effects. Lancet 345: 176-178 [PubMed]
  •  Stein Y., Antal M., Jones M. (1983) A study of the gas-phase pyrolysis of glycerol. J Anal Appl Pyrol 4: 283–296
  • Van Staden S., Groenewald M., Engelbrecht R., Becker P., Hazelhurst L. (2013) Carboxyhaemoglobin levels, health and lifestyle perceptions in smokers converting from tobacco cigarettes to electronic cigarettes. S Afr Med J 103: 865–868 [PubMed]
  • Vardavas C., Anagnostopoulos N., Kougias M., Evangelopoulou V., Connolly G., Behrakis P. (2012) Short-term pulmonary effects of using an electronic cigarette: impact on respiratory flow resistance, impedance, and exhaled nitric oxide. Chest 141: 1400–1406 [PubMed]
  • Werley M., McDonald P., Lilly P., Kirkpatrick D., Wallery J., Byron P., et al. (2011) Non-clinical safety and pharmacokinetic evaluations of propylene glycol aerosol in Sprague-Dawley rats and Beagle dogs. Toxicology 287: 76–90 [PubMed]
  • Wieslander G., Norbäck D., Lindgren T. (2001) Experimental exposure to propylene glycol mist in aviation emergency training: acute ocular and respiratory effects. Occup Environ Med 58: 649–655 [PMC free article] [PubMed]
  • Woolf K., Zabad M., Post J., McNitt S., Williams G., Bisognano J. (2012) Effect of nicotine replacement therapy on cardiovascular outcomes after acute coronary syndromes. Am J Cardiol 110: 968–970 [PubMed]
  • Zevin S., Benowitz N., Jacob P. (1998) Dose-related cardiovascular and endocrine effects of transdermal nicotine. Clin Pharmacol Ther 64: 87–95 [PubMed]

Articles, Responses to other Studies and Letters

© 2014 E-Research Foundation. All Rights Reserved.